Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG. Pediatric blood & cancer

Raquel Dávila Fajardo, Marry M. van den Heuvel-Eibrink, Harm van Tinteren, Filippo Spreafico, Thomas Acha, Christophe Bergeron, Beatriz de Camargo, Foppe Oldenburger, Christian Rübe, Takaharu Oue, Christian Vokuhl, Ronald R. de Krijger, Gordan Vujanic, Neil Sebire, Aurore Coulomb-L'Hermine, Paola Collini, Lorenza Gandola, Kathy Pritchard-Jones, Norbert Graf, Geert O. JanssensMartine van Grotel

Research output: Contribution to journalArticlepeer-review

Abstract

BACKGROUND: As a significant proportion of relapses occurred in the tumor bed or abdomen on patients with the fifth National Wilms Tumor Study stage I anaplastic Wilms tumor (WT), flank radiotherapy was added for stage I anaplastic WT in the subsequent study of the Children's Oncology Group (AREN0321). Preliminary results revealed reduction of relapse rate and improved survival. In cases treated with preoperative chemotherapy, such as in International Society of Pediatric Oncology (SIOP), the value of radiotherapy has never been studied. The aim of this observational study is to describe the pattern of recurrence and survival of patients with stage I diffuse anaplastic WT (DAWT) after induction chemotherapy. METHODS: Retrospective data analysis of the pattern of relapse and survival of all patients with stage I DAWT were included in recent SIOP, L'Associazone Italiana Ematologica Oncologia Pediatrica (AIEOP), Japan Wilms Tumor Study Group (JWiTS), United Kingdom Children's Cancer Study Group (UKCCSG) renal tumor registries. Postoperative treatment consisted of actinomycin D, vincristine, and doxorubicin for 28 weeks without local irradiation. RESULTS: One hundred nine cases with stage I DAWT were identified, of which 95 cases received preoperative chemotherapy. Of these, seven patients underwent preoperative true-cut biopsy. Sixteen of the 95 patients relapsed (17%), six locally, four at distant site, and six combined, and all treated according to SIOP 2001 relapse protocol, which resulted in a 5-year overall survival of 93%. CONCLUSION: Despite 13% locoregional relapse rate, an excellent rescue rate was achieved after salvage treatment, in patients with stage I DAWT whose first-line treatment comprised three-drug chemotherapy (including doxorubicin), without flank irradiation. Therefore, we continue not to advocate the use of radiotherapy in first-line treatment after preoperative chemotherapy in stage I DAWT in the next SIOP protocol.
Original languageEnglish
Pages (from-to)e28039
JournalPediatric Blood and Cancer
Volume67
Issue number2
DOIs
Publication statusPublished - 2020

Keywords

  • Female
  • Humans
  • Male
  • Prospective Studies
  • Child, Preschool
  • Combined Modality Therapy
  • Follow-Up Studies
  • Infant
  • Survival Rate
  • Prognosis
  • Retrospective Studies
  • Clinical Trials as Topic
  • Radiotherapy
  • Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
  • *diffuse anaplasia
  • *radiotherapy
  • *stage I
  • *Wilms tumor
  • Dactinomycin/administration & dosage
  • Doxorubicin/administration & dosage
  • Kidney Neoplasms/*mortality/pathology/therapy
  • Vincristine/administration & dosage
  • Wilms Tumor/*mortality/pathology/therapy

Fingerprint Dive into the research topics of 'Is radiotherapy required in first-line treatment of stage I diffuse anaplastic Wilms tumor? A report of SIOP-RTSG, AIEOP, JWiTS, and UKCCSG. Pediatric blood & cancer'. Together they form a unique fingerprint.

Cite this